Improvement in quality of life for cancer patients treated with epoetin alfa

被引：7
|
作者：
Libretto, SE
Barrett-Lee, PJ
Gorst, DW
Kaczmarski, R
McAdam, K
Stevenson, P
Thomas, R
机构：
[1] Janssen Cilag Ltd, High Wycombe HP14 4HJ, Bucks, England
[2] Velindre Hosp, Clin Trials Unit, Cardiff, S Glam, Wales
[3] Christie Hosp, Adult Leukaemia Unit, Manchester, Lancs, England
[4] Royal Lancaster Infirm, Dept Haematol, Lancaster, England
[5] Hillingdon Hosp, Dept Haematol Med, Uxbridge, Middx, England
[6] Peterborough Dist Gen Hosp, Peterborough, Cambs, England
[7] Newcastle Gen Hosp, Ctr Canc, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England
[8] Bedford Hosp, Primrose Unit, Bedford, Beds, England
来源：
EUROPEAN JOURNAL OF CANCER CARE | 2001年 / 10卷 / 03期
关键词：
human erythropoietin; epoetin alfa; quality of life;
D O I：
10.1046/j.1365-2354.2001.00264.x
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Anaemia is a common complication of cancer and cancer therapies, and fatigue is one of the most common symptoms of anaemia, disrupting functional performance and reducing overall quality of life. The positive effects of treating renal patients with recombinant human erythropoietin are well documented. This case report series details the specific effects of fatigue on individual patients with cancer and their way of life, and describes their significant improvement in lifestyle following the reversal of anaemia using recombinant human erythropoietin, epoetin alfa.
引用
收藏
页码：183 / 191
页数：9
相关论文
共 50 条
  • [41] Epoetin alfa in platinum-treated ovarian cancer patients: results of a multinational, multicentre, randomised trial
    Wilkinson, PM
    Antonopoulos, M
    Lahousen, M
    Lind, M
    Kosmidis, P
    [J]. BRITISH JOURNAL OF CANCER, 2006, 94 (07) : 947 - 954
  • [42] Retrospective study of the appropriate utilization of epoetin alfa and darbepoetin alfa in cancer patients with anemia
    Wong, SF
    Brown, ML
    Sarkisian, R
    [J]. PHARMACOTHERAPY, 2004, 24 (10): : 1452 - 1452
  • [43] Epoetin alfa improves quality of life in anemic HCV-infected patients receiving combination therapy
    Pockros, PJ
    Shiffman, ML
    Schiff, ER
    Sulkowski, MS
    Younossi, Z
    Dieterich, DT
    Wright, TL
    Mody, SH
    Tang, KL
    Goon, BL
    Bowers, PJ
    Leitz, G
    Afdhal, NH
    [J]. HEPATOLOGY, 2004, 40 (06) : 1450 - 1458
  • [44] Epoetin alfa for protection of metabolic and exercise capacity in cancer patients
    Daneryd, P
    [J]. SEMINARS IN ONCOLOGY, 2002, 29 (03) : 69 - 74
  • [45] Epoetin alfa in cancer patients: Evidence-based guidelines
    Turner, R
    Anglin, P
    Burkes, R
    Couture, F
    Evans, W
    Goss, G
    Grimshaw, R
    Melosky, B
    Paterson, A
    Quirt, I
    [J]. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2001, 22 (05) : 954 - 965
  • [46] Epoetin alfa in platinum-treated ovarian cancer patients: results of a multinational, multicentre, randomised trial
    P M Wilkinson
    M Antonopoulos
    M Lahousen
    M Lind
    P Kosmidis
    [J]. British Journal of Cancer, 2006, 94 : 947 - 954
  • [47] Anaemia management with epoetin alfa in lung cancer patients in The Netherlands
    Biesma, Bonne
    van de Werf, Paul R.
    Melissant, Christian F.
    Brok, Ronald G. P. M.
    [J]. LUNG CANCER, 2007, 58 (01) : 104 - 111
  • [48] Epoetin Alfa treatment improved both quality of life and health utility (HUI3) in breast cancer patients receiving chemotherapy
    Chang, Jose
    Couture, Felix
    Lau, Catherine Y.
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 222 - 222
  • [49] Increasing hemoglobin levels with epoetin alfa in anemic hematologic cancer patients receiving chemotherapy correlates significantly with improved quality of life.
    Harousseau, JL
    Fumoleau, P
    Lange, W
    Welslau, M
    [J]. BLOOD, 2004, 104 (11) : 608A - 608A
  • [50] Final report: epoetin alfa maintains hemoglobin levels and quality of life in breast cancer patients during conventional adjuvant chemotherapy.
    Hudis, C
    Williams, D
    Gralow, J
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2002, 76 : S135 - S135
12345